vs

Side-by-side financial comparison of EnerSys (ENS) and DENTSPLY SIRONA Inc. (XRAY). Click either name above to swap in a different company.

DENTSPLY SIRONA Inc. is the larger business by last-quarter revenue ($961.0M vs $919.1M, roughly 1.0× EnerSys). EnerSys runs the higher net margin — 9.8% vs -15.2%, a 25.0% gap on every dollar of revenue. On growth, DENTSPLY SIRONA Inc. posted the faster year-over-year revenue change (6.2% vs 1.4%). EnerSys produced more free cash flow last quarter ($171.3M vs $60.0M). Over the past eight quarters, EnerSys's revenue compounded faster (0.5% CAGR vs 0.4%).

EnerSys is a stored energy systems and technology provider for industrial applications. The company manufactures reserve-power and motive-power batteries, battery chargers, power equipment, battery accessories and outdoor equipment enclosures.

Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.

ENS vs XRAY — Head-to-Head

Bigger by revenue
XRAY
XRAY
1.0× larger
XRAY
$961.0M
$919.1M
ENS
Growing faster (revenue YoY)
XRAY
XRAY
+4.8% gap
XRAY
6.2%
1.4%
ENS
Higher net margin
ENS
ENS
25.0% more per $
ENS
9.8%
-15.2%
XRAY
More free cash flow
ENS
ENS
$111.3M more FCF
ENS
$171.3M
$60.0M
XRAY
Faster 2-yr revenue CAGR
ENS
ENS
Annualised
ENS
0.5%
0.4%
XRAY

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
ENS
ENS
XRAY
XRAY
Revenue
$919.1M
$961.0M
Net Profit
$90.4M
$-146.0M
Gross Margin
30.1%
46.1%
Operating Margin
13.5%
-14.5%
Net Margin
9.8%
-15.2%
Revenue YoY
1.4%
6.2%
Net Profit YoY
-21.3%
66.0%
EPS (diluted)
$2.40
$-0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ENS
ENS
XRAY
XRAY
Q4 25
$919.1M
$961.0M
Q3 25
$951.3M
$904.0M
Q2 25
$893.0M
$936.0M
Q1 25
$974.8M
$879.0M
Q4 24
$906.2M
$905.0M
Q3 24
$883.7M
$951.0M
Q2 24
$852.9M
$984.0M
Q1 24
$910.7M
$953.0M
Net Profit
ENS
ENS
XRAY
XRAY
Q4 25
$90.4M
$-146.0M
Q3 25
$68.4M
$-427.0M
Q2 25
$57.5M
$-45.0M
Q1 25
$96.5M
$20.0M
Q4 24
$114.8M
$-430.0M
Q3 24
$82.3M
$-494.0M
Q2 24
$70.1M
$-4.0M
Q1 24
$60.9M
$18.0M
Gross Margin
ENS
ENS
XRAY
XRAY
Q4 25
30.1%
46.1%
Q3 25
29.1%
48.8%
Q2 25
28.4%
52.4%
Q1 25
31.2%
53.0%
Q4 24
32.9%
49.3%
Q3 24
28.5%
52.1%
Q2 24
27.9%
51.9%
Q1 24
27.9%
53.1%
Operating Margin
ENS
ENS
XRAY
XRAY
Q4 25
13.5%
-14.5%
Q3 25
9.7%
-24.1%
Q2 25
9.7%
-13.7%
Q1 25
13.5%
7.2%
Q4 24
15.7%
-56.2%
Q3 24
11.2%
-48.6%
Q2 24
10.7%
5.1%
Q1 24
8.9%
4.4%
Net Margin
ENS
ENS
XRAY
XRAY
Q4 25
9.8%
-15.2%
Q3 25
7.2%
-47.2%
Q2 25
6.4%
-4.8%
Q1 25
9.9%
2.3%
Q4 24
12.7%
-47.5%
Q3 24
9.3%
-51.9%
Q2 24
8.2%
-0.4%
Q1 24
6.7%
1.9%
EPS (diluted)
ENS
ENS
XRAY
XRAY
Q4 25
$2.40
$-0.74
Q3 25
$1.80
$-2.14
Q2 25
$1.46
$-0.22
Q1 25
$2.39
$0.10
Q4 24
$2.88
$-2.09
Q3 24
$2.01
$-2.46
Q2 24
$1.71
$-0.02
Q1 24
$1.48
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ENS
ENS
XRAY
XRAY
Cash + ST InvestmentsLiquidity on hand
$450.1M
$326.0M
Total DebtLower is stronger
$2.3B
Stockholders' EquityBook value
$1.9B
$1.3B
Total Assets
$4.0B
$5.4B
Debt / EquityLower = less leverage
1.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ENS
ENS
XRAY
XRAY
Q4 25
$450.1M
$326.0M
Q3 25
$388.6M
$363.0M
Q2 25
$346.7M
$359.0M
Q1 25
$343.1M
$398.0M
Q4 24
$463.2M
$272.0M
Q3 24
$407.9M
$296.0M
Q2 24
$344.1M
$279.0M
Q1 24
$333.3M
$291.0M
Total Debt
ENS
ENS
XRAY
XRAY
Q4 25
$2.3B
Q3 25
Q2 25
Q1 25
$1.1B
Q4 24
$1.7B
Q3 24
Q2 24
Q1 24
$802.0M
Stockholders' Equity
ENS
ENS
XRAY
XRAY
Q4 25
$1.9B
$1.3B
Q3 25
$1.9B
$1.5B
Q2 25
$1.9B
$2.0B
Q1 25
$1.9B
$2.0B
Q4 24
$1.8B
$1.9B
Q3 24
$1.8B
$2.5B
Q2 24
$1.8B
$3.1B
Q1 24
$1.8B
$3.3B
Total Assets
ENS
ENS
XRAY
XRAY
Q4 25
$4.0B
$5.4B
Q3 25
$4.1B
$5.7B
Q2 25
$4.1B
$6.1B
Q1 25
$4.0B
$6.0B
Q4 24
$4.0B
$5.8B
Q3 24
$4.0B
$6.6B
Q2 24
$3.6B
$6.9B
Q1 24
$3.5B
$7.1B
Debt / Equity
ENS
ENS
XRAY
XRAY
Q4 25
1.70×
Q3 25
Q2 25
Q1 25
0.57×
Q4 24
0.90×
Q3 24
Q2 24
Q1 24
0.46×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ENS
ENS
XRAY
XRAY
Operating Cash FlowLast quarter
$184.6M
$101.0M
Free Cash FlowOCF − Capex
$171.3M
$60.0M
FCF MarginFCF / Revenue
18.6%
6.2%
Capex IntensityCapex / Revenue
1.4%
4.3%
Cash ConversionOCF / Net Profit
2.04×
TTM Free Cash FlowTrailing 4 quarters
$441.3M
$104.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ENS
ENS
XRAY
XRAY
Q4 25
$184.6M
$101.0M
Q3 25
$218.0M
$79.0M
Q2 25
$968.0K
$48.0M
Q1 25
$135.2M
$7.0M
Q4 24
$81.1M
$87.0M
Q3 24
$33.6M
$141.0M
Q2 24
$10.4M
$208.0M
Q1 24
$25.0M
Free Cash Flow
ENS
ENS
XRAY
XRAY
Q4 25
$171.3M
$60.0M
Q3 25
$197.1M
$40.0M
Q2 25
$-32.1M
$16.0M
Q1 25
$104.9M
$-12.0M
Q4 24
$56.8M
$36.0M
Q3 24
$3.3M
$98.0M
Q2 24
$-25.7M
$156.0M
Q1 24
$-9.0M
FCF Margin
ENS
ENS
XRAY
XRAY
Q4 25
18.6%
6.2%
Q3 25
20.7%
4.4%
Q2 25
-3.6%
1.7%
Q1 25
10.8%
-1.4%
Q4 24
6.3%
4.0%
Q3 24
0.4%
10.3%
Q2 24
-3.0%
15.9%
Q1 24
-0.9%
Capex Intensity
ENS
ENS
XRAY
XRAY
Q4 25
1.4%
4.3%
Q3 25
2.2%
4.3%
Q2 25
3.7%
3.4%
Q1 25
3.1%
2.2%
Q4 24
2.7%
5.6%
Q3 24
3.4%
4.5%
Q2 24
4.2%
5.3%
Q1 24
3.6%
Cash Conversion
ENS
ENS
XRAY
XRAY
Q4 25
2.04×
Q3 25
3.19×
Q2 25
0.02×
Q1 25
1.40×
0.35×
Q4 24
0.71×
Q3 24
0.41×
Q2 24
0.15×
Q1 24
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ENS
ENS

Energy Systems$399.5M43%
Motive Power$352.0M38%
Services$92.6M10%
Transferred Over Time$38.2M4%
Other$36.8M4%

XRAY
XRAY

Essential Dental Solutions$372.0M39%
Equipment And Instruments$160.0M17%
Implants And Prosthetics$150.0M16%
CADCAM$139.0M14%
Wellspect Healthcare$88.0M9%
Orthodontics$52.0M5%

Related Comparisons